BioXcel Therapeutics, Inc. Tax Credit Carryforward, Amount
BioXcel Therapeutics, Inc. (BTAI) had Tax Credit Carryforward, Amount of $10.01 million as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2023-03-16
- 2022-12-31: Tax Credit Carryforward, Amount $10.01M.
- 2021-12-31: Tax Credit Carryforward, Amount $6.45M.
- 2020-12-31: Tax Credit Carryforward, Amount $4.32M.
- 2019-12-31: Tax Credit Carryforward, Amount $1.25M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2022-12-31 | $10.01M 10-K · filed 2023-03-16 |
| 2021-12-31 | $6.45M 10-K · filed 2022-03-11 |
| 2020-12-31 | $4.32M 10-K · filed 2021-03-12 |
| 2019-12-31 | $1.25M 10-K · filed 2020-03-09 |
| 2018-12-31 | $366.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |